Men's Health News

RSS

Overweight increases risk of liver cirrhosis in men

Overweight carries a greatly increased risk of cirrhosis of the liver in men, reveals a new study from the Sahlgrenska Academy. "Given the increasing problem of overweight in Sweden, there is reason to fear that more people will develop cirrhosis of the liver," says Jerzy Kaczynski, docent at the University of Gothenburg and doctor at Sahlgrenska University Hospital.

8 Jun 2011

Ligand's LGD-4033 Phase I clinical trial data presented at the Endocrine Society annual meeting

Ligand Pharmaceuticals Incorporated today announced that data from a comprehensive Phase I multi-dose program with its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation today at the Endocrine Society Annual Meeting in Boston, June 4-7, 2011.

7 Jun 2011

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

BioSante Pharmaceuticals, Inc. today announced that the FDA's clinical hold on the GVAX Prostate Cancer Vaccine for the treatment of prostate cancer has been lifted by FDA.

7 Jun 2011

Exelixis reports encouraging interim data from cabozantinib phase 2 trial for metastatic CRPC

Exelixis, Inc. today reported updated interim data from the fully enrolled cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in a phase 2 adaptive randomized discontinuation trial (RDT).

7 Jun 2011

Non-steroidal, oral contraceptive for men

Researchers at Columbia University Medical Center are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Tests of low doses of a compound that interferes with retinoic acid receptors (RARs), whose ligands are metabolites of dietary vitamin A, showed that it caused sterility in male mice.

7 Jun 2011

Androgen deprivation therapy may increase risk of diabetes in men with prostate cancer

Men with prostate cancer are at higher risk of developing diabetes or diabetes risk factors if they receive androgen deprivation therapy (ADT) to block the production or action of male hormones that can fuel the growth of this cancer.

6 Jun 2011

Weight loss after bariatric surgery may reverse low testosterone, sexual dysfunction in obese men

Low testosterone levels and symptoms of male sexual dysfunction due to obesity may be reversible with weight loss after bariatric surgery, a new study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.

6 Jun 2011

New targeted therapy may halt tumor growth in men with advanced prostate cancer

A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.

6 Jun 2011

Queen's University develops groundbreaking new test for male infertility

A groundbreaking new test for male infertility, which will save time, money and heartache for couples around the world, has been developed at Queen's University Belfast.

6 Jun 2011

Formoterol medication shows promise for improving fat and protein metabolism in men

Formoterol, a new generation asthma medication, shows great promise for improving fat and protein metabolism, say Australian researchers, who have tested this effect in a small sample of men. The researchers presented their results on Saturday 4 June 2011 at The Endocrine Society's 93rd Annual Meeting in Boston.

6 Jun 2011

Study links exposure to BPA with lowered male fertility

Daily exposure to a chemical that is prevalent in the human environment, bisphenol A (BPA), causes lowered fertility in male mice, according to the results of a new study that will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.

6 Jun 2011

Formoterol drug improves fat burning and protein metabolism in men

Formoterol, a medication used to treat asthma and other lung diseases, improves fat burning and protein metabolism in men, a new study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.

6 Jun 2011

SpermComet: New test for male infertility

A new test for male infertility will save time, money and heartache for couples around the world, scientists have claimed. Queen's University Belfast said that more than a decade's research by Professor Sheena Lewis, who leads its Reproductive Medicine research group, had delivered a medical breakthrough.

5 Jun 2011

NHS directive to fertility clinics

NHS fertility clinics will be ordered to meet their responsibilities and provide adequate levels of IVF treatment, amid growing concerns. There are claims that a “postcode lottery” is reducing couples' chances of having a baby.

5 Jun 2011

Combinations of mother's body size, placental size can predict heart disease in men in later life: Study

Researchers investigating the foetal origins of chronic disease have discovered that combinations of a mother's body size and the shape and size of her baby's placenta can predict heart disease in men in later life.

4 Jun 2011

SBRT is effective for patients with low-to-intermediate-risk prostate cancer: Researchers

In a multicenter clinical trial, UT Southwestern Medical Center researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer.

4 Jun 2011

Sexual pleasure among young adults linked to healthy psychological and social development

Sexual pleasure among young adults (ages 18-26) is linked to healthy psychological and social development, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Jun 2011

APC8015F investigational vaccine improves survival of prostate cancer patients

Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data being presented by researchers from the Kimmel Cancer Center at Jefferson at the 2011 American Society of Clinical Oncology annual meeting in Chicago on Saturday, June 4.

3 Jun 2011

Itraconazol may keep prostate cancer from worsening and delay need for chemotherapy in men

The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease.

3 Jun 2011

Stereotactic body radiation therapy effective for patients with low-risk prostate cancer

3 Jun 2011

Men's Health News

Overweight increases risk of liver cirrhosis in men

Ligand's LGD-4033 Phase I clinical trial data presented at the Endocrine Society annual meeting

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

Exelixis reports encouraging interim data from cabozantinib phase 2 trial for metastatic CRPC

Non-steroidal, oral contraceptive for men

Androgen deprivation therapy may increase risk of diabetes in men with prostate cancer

Weight loss after bariatric surgery may reverse low testosterone, sexual dysfunction in obese men

New targeted therapy may halt tumor growth in men with advanced prostate cancer

Queen's University develops groundbreaking new test for male infertility

Formoterol medication shows promise for improving fat and protein metabolism in men

Study links exposure to BPA with lowered male fertility

Formoterol drug improves fat burning and protein metabolism in men

SpermComet: New test for male infertility

NHS directive to fertility clinics

Combinations of mother's body size, placental size can predict heart disease in men in later life: Study

SBRT is effective for patients with low-to-intermediate-risk prostate cancer: Researchers

Sexual pleasure among young adults linked to healthy psychological and social development

APC8015F investigational vaccine improves survival of prostate cancer patients

Itraconazol may keep prostate cancer from worsening and delay need for chemotherapy in men

Stereotactic body radiation therapy effective for patients with low-risk prostate cancer

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News